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Linear IgA bullous dermatosis (LABD) is a rare autoimmune blistering disease that may 
be triggered by some diseases and medications. For the latter one, non-steroidal anti-
inflammatory drugs (NSAIDs) have been identified as one of the potential causative agents 
to develop LABD. Here, a rare case of drug-induced LABD is introduced. A 13-month-old 
Iranian boy presented with a history of generalized blisters, displaying the classic “string of 
pearls” sign who was eventually diagnosed as a case of LABD. In his admission, he was 
diagnosed whit Mucocutaneous lymph node syndrome and treated with aspirin.  Some 
features like appearing the characteristic lesions one week following the administration of 
aspirin, rapid clearance of lesions after the withdrawal of the drug, and reappearance of new 
lesions after readministration of aspirin were highly suggestive of aspirin-induced LABD. To 
establish the diagnosis, we used the “Naranjo probability score” which determined the 
probable causative role of aspirin. The diagnosis was confirmed by showing the positive IgA 
deposition in the basement membrane zone in a direct immunofluorescence study of the 
skin biopsy. The child was treated with dapsone with dramatical response to the drug. 
 





Linear IgA bullous dermatosis (LABD) is a rare 
skin bullous condition in young children and adults. 
The causes of LABD are unknown, it is considered to 
be an autoimmune disease. Certain medications can 
cause LABD. In these cases, the blisters appear after 
starting the medication and disappear after stopping it. 
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Other reported causative diseases include some 
systemic autoimmune and non-autoimmune diseases.
1-6 
Patients have itchy tense blisters with a clear fluid, 
often arranged in clusters or rings so-called “cluster of 
jewels”, “string of pearls” affecting the skin with 
occasional mucosal involvement. The diagnosis is 
usually confirmed with a skin biopsy. Special staining 
and direct immune fluorescence (DIF) show the 
deposition of the IgA in the skin along the basement 
membrane zone (BMZ).
1-6  
The treatment of choice is dapsone with the main 
adverse effects of methemoglobinemia and hemolytic 
anemia. Other treatments include systemic and topical 
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corticosteroids, sulfapyridine, colchicine, 
like dicloxacillin, oxacillin, trimethoprim/
sulfamethoxazole, flucloxacillin, e
Immunosuppressants like cyclophosphamide
cyclosporine, mycophenolate mofetil and 
immunoglobulin (IVIG) taken in patients 
respond to the above-mentioned drugs.
1-8
 
In the medical literature, there are only 
reports regarding the role of non-steroidal anti
inflammatory drugs (NSAIDs) in the pathogenesis of 
LABD.
3
We report a new case of drug-induced LABD 




A 13-month-old boy was referred to the clinic of 
Allergy and Immunology with a generalized blistering 
skin eruption. He was diagnosed as atypical 
mucocutaneous lymph node syndrome 
a history of high fever lasting for 10 days associated 
with non-purulent conjunctivitis, ESR=57, CRP=20
and dilated mild right coronary artery (RCA) and left 
coronary artery (LCA) without aneurysm in 
echocardiography. The patient was treated 
dose aspirin (80 mg/kg) and IVIG and discharged with 
daily use of low dose aspirin (5mg/kg)
recommended for a two-week follow-up visit.
One week after the administration of 
patient started to develop generalized eruption as 
grouped tense blisters, localized initially in the 
perineum and testis and progressed to the trunk, face
and extremities. Several vesicles were seen at the edge 
of the annular lesion, representing the classic “string of 
beads” sign (Figure 1A and B). Palmar and plantar 
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Figure 1. A, B) Characteristic lesions in Linear IgA Bullous Dermatosis 
lesions after treatment D) complete improved lesions after treatment with dapsone
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surfaces were not involved. There was no report of any 
mucosal involvement including eyes. Aspirin was 
discontinued as a possible culprit agent.
Medical history and clinical examination ruled out 
the presence of common triggers of erythema 
multiform such as herpes virus infection. Tzank smear 
showed many neutrophils and some histiocytes 
without any pieces of evidence 
infection. Differential blood count was normal except 
thrombocytosis (possibly due to previous 
mucocutaneous lymph node syndrome
period) without neutrophilia or eosinophilia. There 
was no change in liver function parameters. Serum 
levels of immunoglobulins including IgA were within 
normal limits. A skin biopsy was taken from a trunk 
lesion and in histopathological examination showed 
subepidermal bullae with predominantly eosinophils 
and some neutrophils entrapped in a fibrin network 
associated with perivascular lymphocytic infiltration 
and some interstitial eosinophils (Figure 2
C). DIF examination demonstrated linear deposits of 
IgA along the BMZ, without IgG and C3 deposits, 
consistent with a diagnosis of Linear IgA bullous 
dermatosis. 
The child was treated with topical corticosteroid 
and dapsone (0.5 mg/kg/day) after measuring of 
glucose-6-phosphate dehydrogenase activity and slowly 
increased until 2 mg/kg/day. The characteristic lesions 
of LABD began to regress dramatically in 
The target lesions improved soon with some remaining 
post-inflammatory hyperpigmentations (PIH) (Figure 
1C). Dapsone, 2 mg/kg daily, is well tolerated by the 
patient and continued despite clearance of all lesions to 
prevent any possible relapse of the lesions (Figure 1D).
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Figure 2. A, B, C) Skin biopsy from a trunk lesion and histopathological examination with hematoxylin and eosin (H&E) 
staining showed subepidermal bullae with predominantly eosinophils and some neutrophils entrapped in a fibrin network 








Table 1. Differential diagnosis of blistering diseases according to the age of onset 
Children Adult 
Bullous impetigo 
Bullous papular urticaria 




Atypical erythema multiforme 
Bullous pemphigoid 
Bullous systemic lupus erythematosus 
Dermatitis herpetiformis 
Excoriated nodular prurigo 
Steven johnson syndrome 
Toxic epidermal necrolysis 
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In a one-month cardiology follow-up visit, aspirin 
was readministered to prevent any cardiac 
complications of mucocutaneous lymph node 
syndrome. Skin lesions reappeared in less than 72 
hours that included new bullous lesions in the trunk and 
acral regions. Therefore, aspirin immediately 




Linear IgA Bullous Dermatosis (LABD) is a rare 
autoimmune bullous dermatosis, but the most common 
autoimmune bullous dermatosis in children.
2-5,8
 
The immune system produces IgA antibodies which 
are incorrectly and linear deposited in the top layer of 
the skin and can cause damage to the structure of the 
skin, as a result, a blister appears.
1,2,8
 
LABD may be triggered by some causes as 
prodromal diseases including upper airway or urinary 
tract infections, brucellosis, salmonella enteritis, 
immunization (varicella or influenza vaccine), systemic 
autoimmune diseases (systemic lupus erythematosus, 
psoriasis, rheumatoid arthritis, dermatomyositis, 
Crohn's disease, ulcerative colitis), malignancies 
(Hodgkin’s disease, B cell lymphoma, Bladder cancer, 
esophageal cancer) and others.1-4 Drugs such as 
antibiotics, analgesics, antihypertensives, antiepileptics, 
or immunosuppressants have been identified as 
potential causative agents to develop LABD.
1-3
 
Antibiotics and NSAIDs are most frequent in children.4 
Because LABD is clinically indistinguishable from 
other autoimmune bullous dermatoses, other 
differentials should be considered.
1,2,4
 (Table 
1).Diagnosis of LABD requires a high index of 
suspicion and early confirmation with dermopathologic 
studies and specific staining technics like DIF.1-3,8 
Histologically, subepidermal blisters are observed in 
association with neutrophilic and eosinophilic 
infiltration, which is also observed in bullous 
pemphigoid and dermatitis herpetiform.1,2,4,5Although, 
the clinical presentation with “string of pearls” 
appearance is highly characteristic for LABD, but a 
definitive diagnosis is based on DIF, which is 
pathognomonic for LABD, revealing linear deposits of 
IgA on the BMZ.
1,2,8
 Mucosal involvement was seen in 
45.5% children and 14.8% adult patients with LABD, 
but there is no mucosal involvement in our patient.
4,9 
Early diagnosis is important for proper management 
because discontinuing the culprit drug is most crucial.
6
 
It may be challenging to identify the causative agent of 
LABD because many patients are treated with multiple 
drugs.1,2,4 The use of the Naranjo algorithm to estimate 
the probability of adverse drug reaction can help in 
establishing the correct diagnosis.3,6,10 
In our presenting case, there were many findings 
highly suggestive of aspirin-induced LABD such as the 
appearance of characteristic lesions one week after 
administration of aspirin, rapidly clearance of the 
lesions after the withdrawal of the drug, lack of 
mucosal involvement, reappearing new lesions after 
readministration of aspirin and IgA deposition and not 
IgG and C3 in BMZ in DIF study. To establish the 
diagnosis of aspirin-induced LABD, we applied the 
Naranjo algorithm, based on the answer to 10 
questions, to reach a correct “causality assessment” 
between the suspected drug (aspirin) and the adverse 
event. Naranjo probability scale implies an adverse 
drug reaction score of <2: doubtful; 2 - 4: possible; 5 - 
8: probable; >9: definite.
10
 We achieved a score of 6 in 
this case which determined the probable causative role 
of aspirin. 
Up to date, there are only a few case reports of  
NSAID-induced LABD including only one case of the 
aspirin-induced disease. NSAIDs such as piroxicam, 
diclofenac, and naproxen are some culprits that have 
been previously reported.11-14 In 2017, Gatto et al, 
reported the first case of aspirin-induced LABD with a 
possible association, following aspirin use in the 
management of cold in a two-year-old boy.
14
 In other 
forms of autoimmune bullous dermatoses, Durda et al 
reported a case of bullous pemphigoid related to aspirin 
in a 76-year-old man in Turkey in the 2010.15 
The pathogenesis of LABD remains unclear. 
However, more studies are needed for a better 
understanding of the pathogenesis, trigger factors, and 
optimal treatment of LABD. 
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